Lifeforce Capital is a venture capital firm that invests in software companies reshaping the status quo in healthcare's largest markets. The firm focuses on software-driven companies and software-first techbio platforms that improve care delivery and enable more efficient therapeutic development.
38% of their portfolio is in Biotech & Life Sciences. They made 3 investments in the last 12 months. Their most common stage is series-a (46% of deals). Average disclosed round size is $53.7M (across 23 rounds with reported amounts).
Portfolio
24
Fund Size
—
Top Stage
Series A
Last 12 Mo
3
Team
JN
John Noonan
Managing Partner
AP
Adam Pelavin
Partner
SB
Sudhir Bahl
Founder & CEO
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
26 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 CareCubes | Series A | $6.5M | Mar 2026 |
 Aspen Neuroscience | Series C | $115M | Nov 2025 |
| AAspen Neuroscience | Series C | $115M | Nov 2025 |
 Vilya Therapeutics | Series A | $71M | Jun 2024 |
 Vilya | Series A | $71M | Jun 2024 |
 Ochre Bio | Unknown | $30M | Oct 2022 |
 Mindright | Seed | — | Jun 2022 |
| Aspen Neuroscience | Series B | $147.5M | May 2022 |
 PostEra | Series A | $24M | Jan 2022 |
 Fauna Bio | Seed | $9M | Sep 2021 |
 Sonoma Biotherapeutics | Series B | $265M | Aug 2021 |
 Bayesian Health | Unknown | $15M | Jul 2021 |
 Sitka | Series A | $14M | Feb 2021 |
 Sitka | Unknown | $14M | Feb 2021 |
 Mythic Therapeutics | Series B | $103M | Jan 2021 |
 Vineti | Series C | $35M | Feb 2020 |
 Cricket Health | Series A | $24M | Sep 2018 |
 Verge Genomics | Series A | — | Jul 2018 |
 Senti Biosciences | Series A | $53M | Feb 2018 |
 Second Genome | Series B | $8.4M | Apr 2016 |
 TARA Biosystems | Seed | $2.3M | Jan 2014 |
 Gauss | Series B | — | — |
| Gauss | Series A | $12M | — |
 Vivante Health | Series A | $16M | — |
 64x | Series A | $55M | — |
Page 1 of 2
Top Co-Investors
ARCH Venture Partners6 shared
First Round Capital5 shared
S324 shared
Y Combinator4 shared
Menlo Ventures3 shared
Kite, a Gilead Company3 shared
OrbiMed3 shared
LYFE Capital3 shared
Revelation Partners3 shared
Frazier Life Sciences3 shared
Alexandria Venture Investments3 shared
Venrock3 shared
8VC2 shared
Allen & Company LLC2 shared
BoxGroup2 shared
Casdin Capital2 shared
Altitude Life Science Ventures2 shared
Madrona Venture Group2 shared
Cormorant Asset Management2 shared
Axon Partners Group2 shared
Last updated: 8 September 2026